Bridgebio Pharma Inc (BBIO)

SG&A Expense Growth

13.65%

Quarterly · Period ending:

BBIO logo

BBIO SG&A Expense Growth

Latest reported13.65%
BBIO Quarterly SG&A Growth (QoQ) (0.00% → 13.65%)
High-resolution chart · PNG

BBIO sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
13.6458%
-9.9473%
32.2473%
6.5557%
21.4253%
12.2207%
37.7265%
15.6175%
-9.5491%
38.2994%
32.9989%
-0.9551%
16.118%
-2.3665%
2.1611%
-14.3798%
-16.6701%
-20.1574%
18.8026%
0.248%
1.2399%
21.2891%
3.9455%
-5.1437%
10.8196%
-2.0302%
48.8487%
38.3117%
-10.1169%
31.4165%
39.513%
-5.353%
36.0185%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.